Karnon, Jonathan <br/><br/>
Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation.  [electronic resource] 

 -  PharmacoEconomics  2002 
 - 119-37 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1170-7690 
<br/><br/><label>Standard No.: </label>10.2165/00019053-200220020-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticarcinogenic Agents--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Cost-Benefit Analysis<br/>Disease Progression<br/>Female<br/>Humans<br/>Middle Aged<br/>Models, Economic<br/>Reproducibility of Results<br/>Tamoxifen--adverse effects